tirzepatide semaglutide differences comparison vs The Difference Between Semaglutide and
Description
Semaglutide activates only GLP-1 receptors
The trial demonstrated that once-weekly tirzepatide 10 mg and 15 mg offered substantial and clinically meaningful bodyweight reduction, with a safety profile similar to other therapies for weight management using incretin-based approaches
The practical takeaway is this
Mol Metab 46:101090 [DOI] [PMC free article] [PubMed] Bailey CJ (2020) GIP analogues and the treatment of obesity-diabetes
Weeks 17 Through 24: Reaching Full Dose (12.5 mg to 15 mg) If your provider has you titrating to the maximum dose, youll reach 15 mg around week 20
